Rheumatoid Arthritis: What to Know
Rheumatoid arthritis is driven by an immune system that attacks the joints. Researchers are studying whether mesenchymal stem cells can help regulate that immune response, and results vary.
- Autoimmune
- 2 min
04/04/2026
When Immunity Turns on the Joints
Rheumatoid arthritis is an autoimmune disease. The immune system attacks the lining of the joints, which becomes inflamed, swollen and painful. It often affects both sides of the body at once, starting in the hands, wrists and feet. Over time, ongoing inflammation can damage cartilage and bone, and many people also live with fatigue and morning stiffness.
Standard Treatment Today
Rheumatologists treat the disease with disease-modifying drugs, biologic medicines and, at times, steroids. Many patients respond well. Others find that their symptoms persist or that side effects make long-term use difficult, and some of them begin to ask about regenerative options.
Why Researchers Study These Cells
Mesenchymal stem cells interact with immune cells and release molecules that may influence inflammation. Researchers are investigating whether this effect can lower disease activity in rheumatoid arthritis. Most studies so far are early and small, and the results are not the same for every patient.
Cell therapy is studied as an addition to standard care. Patients should never stop a prescribed medication without speaking to their rheumatologist.
Researchers measure progress with blood markers of inflammation, joint counts and questionnaires about daily function, so changes can be tracked over months.
Our Cells and Approach
At Regeneration Clinic we use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory. Because rheumatoid arthritis affects the whole body, treatment is usually given as an intravenous infusion, and your doctor may add injections into specific joints.
Is It Right for You?
A medical evaluation decides whether treatment is appropriate. Your doctor will review your diagnosis, current disease activity, medications and any other health conditions, then explain what is realistic in your case. We check in at 1, 3, 6, 9 and 12 months after treatment.
04/04/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






